The global ophthalmic photocoagulator market is anticipated to expand at a CAGR of 4.2% during the forecast period, 2021-2028. The growth of the market is attributed to rising prevalence of eye-related disorder across the globe.
Photocoagulation is a type of laser surgery used to repair damaged tissue performing under an ophthalmic photocoagulator. An ophthalmic photocoagulator is a medical device utilized to treat ophthalmic defects and eye cells. It's highly adopted for clinical and therapeutic purposes. This device consists of a laser host, power cord, foot switch, remote control, slit lamp adapter, and sterile intraocular probe. During the photocoagulation process, ophthalmologists use argon, dye, krypton, and diode to coagulate defected tissue in the retina. Photocoagulator disinfects the blood vessels with the heat generated by light source, usually laser beam.
The report on the ophthalmic photocoagulator market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Ophthalmic Photocoagulator Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast |
Base Year |
2020 |
Historic Data |
2018 & 2019 |
Forecast Period |
2021–2028 |
Segmentation |
Applications (Retinal Laser, Photocoagulation, and Laser Trabeculoplasty) Medical Conditions (Diabetic Retinopathy, Age-related Macular Degeneration, and Glaucoma), End-users (Hospitals, Clinics, Ambulatory Services, and Ophthalmology Centers) |
Regional Scope |
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
Report Coverage |
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
Key Players Covered in the Report |
Quantel Medical, Alcon, ALMA, Lumenis, NIDEK, Meridian, Iridex corporation, Valon Lasers, Ellex Medical Laser, and Lombort. |
Based on applications, the market can be divided into retinal laser, photocoagulation, and laser trabeculoplasty.
The retinal laser segment is anticipated to expand at a CAGR of 6.3% during the forecast period. Rising incidence of macular degeneration in geriatric population is driving the market segment growth. On the other hand, the laser trabeculoplasty segment is estimated to account a major market share due to rising interest for insignificant obtrusive strategy over the conventional technique is fueling the market segment.
On the basis of medical conditions, the ophthalmic photocoagulator market can be segmented into diabetic retinopathy, age-related macular degeneration, and glaucoma.
The diabetic retinopathy segment is anticipated to account a significant market share in the coming years. This is due to the rising predominance of target illness, for example, diabetes and different eye-related persistent issues. However, the glaucoma segment is estimated to exhibit a robust CAGR during the forecast period. As per the American Academy of Ophthalmology, glaucoma influences more than 2.7 million Americans over age 40.
In term of end-users, the market is classified as hospitals, clinics, ambulatory services, and ophthalmology centers. The hospitals segment is anticipated to constitute a major market share during the forecast period. The presence of favorable reimbursement policies is driving the growth of the market segment. Increasing spending on healthcare facilities is further propelling the segment growth.
Based on regions, the ophthalmic photocoagulator market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
The market in North America is anticipated to exhibit a robust CAGR during the forecast period. The presence of major industry players and awareness is driving the regional market growth. Many market players are zeroing in on getting FDA endorsements for the innovative ophthalmic arrangement and gadgets. For example, Johnson and Johnson Vision has received an FDA endorsement for another laser eye a medical procedure sign for its iDesign Refractive Studio framework.
Asia Pacific is expected to account for a considerable market share in the coming years. Rising investment in healthcare facilities, especially in emerging economies such as India and China, is spurring the regional market growth. Moreover, rising geriatric population and awareness about the treatment are major factors fueling the market in Asia Pacific.
The global ophthalmic photocoagulator market has been segmented on the basis of
The main players for the market of ophthalmic photocoagulators are Quantel Medical, Alcon, ALMA, Lumenis, NIDEK, Meridian, Iridex corporation, Valon Lasers, Ellex Medical Laser, and Lombort.
The global ophthalmic photocoagulator market has been segmented on the basis of
The main players for the market of ophthalmic photocoagulators are Quantel Medical, Alcon, ALMA, Lumenis, NIDEK, Meridian, Iridex corporation, Valon Lasers, Ellex Medical Laser, and Lombort.
Some other reports from this category!